Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy

Gorecki, L; Andrs, M; Rezacova, M; Korabecny, J

PHARMACOLOGY & THERAPEUTICS, 2020; 210 ():

Abstract

Chemoresistance, radioresistance, and the challenge of achieving complete resection are major driving forces in the search for more robust and targete......

Full Text Link